These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 7529414)

  • 1. The chemistry of signal transduction.
    Clardy J
    Proc Natl Acad Sci U S A; 1995 Jan; 92(1):56-61. PubMed ID: 7529414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE
    Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
    [No Abstract]   [Full Text] [Related]  

  • 3. Three-dimensional structure and actions of immunosuppressants and their immunophilins.
    Braun W; Kallen J; Mikol V; Walkinshaw MD; Wüthrich K
    FASEB J; 1995 Jan; 9(1):63-72. PubMed ID: 7529736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
    Bell A; Wernli B; Franklin RM
    Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases.
    Kay JE
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):361-85. PubMed ID: 8670043
    [No Abstract]   [Full Text] [Related]  

  • 6. Design and synthesis of a rapamycin-based high affinity binding FKBP12 ligand.
    Chakraborty TK; Weber HP; Nicolaou KC
    Chem Biol; 1995 Mar; 2(3):157-61. PubMed ID: 9383417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK506-binding protein mutational analysis: defining the active-site residue contributions to catalysis and the stability of ligand complexes.
    DeCenzo MT; Park ST; Jarrett BP; Aldape RA; Futer O; Murcko MA; Livingston DJ
    Protein Eng; 1996 Feb; 9(2):173-80. PubMed ID: 9005438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational polymorphism in peptidic and nonpeptidic drug molecules.
    Taylor P; Mikol V; Kallen J; Burkhard P; Walkinshaw MD
    Biopolymers; 1996; 40(5):585-92. PubMed ID: 9101762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A.
    Cardenas ME; Muir RS; Breuder T; Heitman J
    EMBO J; 1995 Jun; 14(12):2772-83. PubMed ID: 7540976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from molecular matchmakers.
    Teague S
    Nat Struct Biol; 1995 May; 2(5):360-1. PubMed ID: 7545076
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunophilins, ligands, and the control of signal transduction.
    Schreiber SL; Crabtree GR
    Harvey Lect; 1995-1996; 91():99-114. PubMed ID: 9127988
    [No Abstract]   [Full Text] [Related]  

  • 12. Peptidylproline cis/trans isomerases.
    Galat A; Metcalfe SM
    Prog Biophys Mol Biol; 1995; 63(1):67-118. PubMed ID: 7538221
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands.
    Cardenas ME; Hemenway C; Muir RS; Ye R; Fiorentino D; Heitman J
    EMBO J; 1994 Dec; 13(24):5944-57. PubMed ID: 7529175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of immunosuppressive agents.
    Borel JF; Baumann G
    Bull Mem Acad R Med Belg; 1994; 149(1-2):97-101; discussion 101-3. PubMed ID: 7531051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myristoylation of calcineurin B is not required for function or interaction with immunophilin-immunosuppressant complexes in the yeast Saccharomyces cerevisiae.
    Zhu D; Cardenas ME; Heitman J
    J Biol Chem; 1995 Oct; 270(42):24831-8. PubMed ID: 7559604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.
    Kunz J; Hall MN
    Trends Biochem Sci; 1993 Sep; 18(9):334-8. PubMed ID: 7694398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analogous conformations of both binding and effector regions in cyclosporin A, FK506 and rapamycin.
    Denesyuk AI; Denessiouk KA; Zav'yalov VP; Lundell J; Korpela T
    Comput Chem; 1998 Jun; 22(4):339-44. PubMed ID: 9680690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin.
    Ryffel B; Weber E; Mihatsch MJ
    Exp Nephrol; 1994; 2(6):324-33. PubMed ID: 7532090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin.
    Cardenas ME; Zhu D; Heitman J
    Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):472-7. PubMed ID: 8591053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressant target protein FKBP12 is required for P-glycoprotein function in yeast.
    Hemenway CS; Heitman J
    J Biol Chem; 1996 Aug; 271(31):18527-34. PubMed ID: 8702500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.